ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s share price dropped 5.6% during trading on Friday . The stock traded as low as $1.64 and last traded at $1.67. Approximately 327,675 shares changed hands during trading, an increase of 1,512% from the average daily volume of 20,327 shares. The stock had previously closed at $1.77.
ImmunoPrecise Antibodies Stock Up 7.3%
The business’s 50 day moving average is $1.73 and its 200-day moving average is $1.61.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- What is the Euro STOXX 50 Index?
- Worried About Inflation? These 3 ETFs Offer Real Protection
- Best Stocks Under $5.00
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
